Breast Cancer

Article	Citations
Integrated analysis of cell cycle-related genes in HR+/HER2− breast cancer	123
The hub ten gene-based risk score system using RNA m6A methylation regulator features and tumor immune microenvironment in breast cancer	55
Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort stud	44
Identification of key tumor stroma-associated transcriptional signatures correlated with survival prognosis and tumor progression in breast cancer	41
Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast can	41
Validation of a nuclear grading system for resected stage I–IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial	34
Reply to “Is venous thromboembolism a time-dependent event in breast cancer patients taking tamoxifen?”	30
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients	27
Quality of life improvement in breast cancer survivors affected by upper limb lymphedema through a novel multiperspective physical activity methodology: a monocentric pilot study	26
Average lifespan shortened due to breast cancer in Australia, 1990–2015	25
Number of lines of previous chemotherapy regimen might affect the oucome of sacituzumab govitecan in metastatic triple-negative breast cancer patients	25
Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line	23
Identifying ductal carcinoma in situ cases not requiring surgery to exclude postoperative upgrade to invasive ductal carcinoma	23
New variant of breast-invasive lobular carcinoma with solid and encapsulated papillary carcinoma growth pattern	22
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within breast cancer subtypes and stages among older women: a SEER-Medicare analysis	21
Correction: Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort study	21
Oncoplastic versus conventional breast-conserving surgery in breast cancer: a pooled analysis of 6941 female patients	21
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment	20
Community-based outpatient rehabilitation for the treatment of breast cancer-related upper extremity disability: an evaluation of practice-based evidence	20
Factors associated with post acute care utilization after mastectomy for breast cancer patients	19
The role of C1orf50 in breast cancer progression and prognosis	18
Detection capability of the Medical Imaging Projection System for sentinel lymph node biopsy in patients with breast cancer with and without neoadjuvant chemotherapy: a retrospective study	17
Impact of the COVID-19 pandemic on breast cancer diagnosis and treatment trends in Japan	15
Factors associated with non-participation in breast cancer screening: analysis of the 2016 and 2019 comprehensive survey of living conditions in Japan	14
Trastuzumab deruxtecan versus treatment of physician’s choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study	14

SET-binding protein 1 (SETBP1) suppresses cell proliferation in estrogen receptor-positive breast cancer	14
Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1)	13
The involvement of axillary reverse mapping nodes in patients with clinically node-negative breast cancer	13
ATPase copper transporting beta attenuates malignant features with high expression as an indicator of favorable prognosis in breast cancer	12
ER–/PR+ breast cancer is controlled more effectively with an inflammatory inhibitor than hormonal inhibitor	12
Relevance of the MHC region for breast cancer susceptibility in Asians	12
Glutaminase (GLS1) gene expression in primary breast cancer	12
Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer: an international pooled analysis of individual p	12
Influence of age on patient decision regret following breast reconstruction: a multicenter collaborative study in Japan	12
Investigation of recurrence prediction ability of EndoPredict® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict® from	12
Hepatitis C virus may accelerate breast cancer progression by increasing mutant p53 and c-Myc oncoproteins circulating levels	11
Efficacy and safety of surgical energy devices for axillary node dissection: a systematic review and network meta-analysis	11
Utility of a breast biopsy clip and a point marker system in tailored axillary surgery for patients with breast cancer after neoadjuvant chemotherapy	11
HER2-targeted antibody–drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia	11
Prognostic impact of tumor‑associated stroma in triple-negative breast cancer	11
c-Myc knockdown restores tamoxifen sensitivity in triple-negative breast cancer by reactivating the expression of ERα: the central role of miR-152 and miR-148a	11
6q deletion is frequent but unrelated to patient prognosis in breast cancer	10
Association between chronic pain and quality of life in long-term breast cancer survivors: a prospective analysis	10
Quercetin: a silent retarder of fatty acid oxidation in breast cancer metastasis through steering of mitochondrial CPT1	10
Comparison of locoregional recurrence risk among nipple-sparing mastectomy, skin-sparing mastectomy, and simple mastectomy in patients with ductal carcinoma in situ: a single-center study	10
21-gene recurrence score predictive of the benefit of postoperative radiotherapy after breast-conserving surgery for elderly patients with T1N0 and luminal breast cancer	10
Impact of exercise interventions on physical fitness in breast cancer patients and survivors: a systematic review	10
Breast cancer screening guidelines: discrepancies raise concerns about validity	10
Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple-negative breast cancer: an impact on classification and treatment approaches	10
Resilience’s impact on quality of life and post-traumatic growth in breast cancer patients during treatment	10
Concordance of HER2 status between core needle biopsy and surgical resection specimens of breast cancer: an analysis focusing on the HER2-low status	9
FE65 in breast cancer and its clinicopathological significance	9
Radiation-induced angiosarcoma of the breast: individual participant meta-analysis of Japanese population	9
Reevaluating HER2-null breast cancer using an enhanced HER2 immunohistochemistry protocol	9
What do we know about treating breast-cancer-related lymphedema? Review of the current knowledge about therapeutic options	9
Immunohistological analysis of B7-H4, IDO1, and PD-L1 expression and tumor immune microenvironment based on triple-negative breast cancer subtypes	9
Resveratrol exhibits diverse anti-cancer activities through epigenetic regulation of E-cadherin and p21 in triple-negative breast cancer cells	9
Impact of artificial intelligence in breast cancer screening with mammography	9
Pre-pectoral breast reconstruction: early and long-term safety evaluation of 146 unselected cases of the early pre-pectoral era of a single-institution, including cases with previous breast irradiatio	9
Targeted therapies in HER2-positive breast cancer with receptor-redirected Arazyme-linker-Herceptin as a novel fusion protein	9
Color differences of skin paddles using the free flap for autologous breast reconstruction in Asian patients	9
Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of triple-negative breast cancer in humanized mouse models	8
Capecitabine with aromatase inhibitors in the front-line therapy for metastatic breast cancer	8
Dynamic changes in quality of life, psychological status, and body image in women who underwent a mastectomy as compared with breast reconstruction: an 8-year follow up	8
Acute toxicity of hypofractionated radiotherapy for Japanese breast cancer patients after surgery: a single center prospective observational study (HyPORT-BC)	8
Association between preoperative grip strength and postoperative upper extremity impairments in patients with breast cancer: a retrospective cohort study	8
Tumor mutational burden status and clinical characteristics of invasive lobular carcinoma of the breast	8
The effect of combined risk factors on breast cancer-related lymphedema: a study using decision trees	8
Reevaluating ALND omission and its impact on abemaciclib eligibility and treatment decisions	7
Clinicopathological differences and survival benefit in ER+/PR+/HER2+ vs ER+/PR−/HER2+ breast cancer subtypes	7
Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort	7
Characteristics of female breast cancer in japan: annual report of the National Clinical Database in 2018	7
Does axillary lymph node recurrence breast cancer subtype information matter for prognosis estimation?	7
Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer with TP53 pathogenic variant carriers	7
Breast cancer statistics for Japan in 2022: annual report of the national clinical database-breast cancer registry—clinical implications including chemosensitivity of breast cancer with low estrogen r	7

Prognostic effect of subsequent childbirth after the diagnosis of breast cancer using propensity score matching analysis	7
Alcohol consumption and breast lesions: targets for risk-based screening in high-risk Italian women	6
Identification of prognostic genes signature and construction of ceRNA network in pirarubicin treatment of triple-negative breast cancer	6
Sensitivity and specificity of screening mammography without clinical breast examination among Japanese women aged 40–49 years: analysis of data from the J-START results	6
Psychometric evaluation of the Chinese version of the breast cancer perception scale for community women: a translation and validation study	6
Identification and validation of screening models for breast cancer with 3 serum miRNAs in an 11,349 samples mixed cohort	6
The effectiveness of moisturizer on acute radiation-induced dermatitis in breast cancer patients: a systematic review and meta-analysis	6
Medical care costs according to the stage and subtype of breast cancer in a municipal setting: a case study of Hachioji City, Japan	6
Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflow	6
Efficacy and safety of adjuvant therapies in older patients with breast cancer: a systematic review and meta-analysis of real-world data	6
Management of nausea and vomiting induced by antibody–drug conjugates	6
Correction: The Japanese breast cancer society clinical practice guidelines for breast cancer screening and diagnosis, 2022 edition	6
Global untargeted and individual targeted plasma metabolomics of breast cancer recurrence modified by hormone receptors	6
Overexpression of MCAM induced by SMYD2-H3K36me2 in breast cancer stem cell properties	6
Development of a nomogram to predict recurrence scores obtained using Oncotype DX in Japanese patients with breast cancer	6
Impact of oral hygiene on febrile neutropenia during breast cancer chemotherapy	6
Performance analysis of screening mammography in Asian women under 40 years	6
Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants	6
Japanese translation of the Functional Assessment of Cancer Therapy-Breast + 4 (FACT-B + 4) following international guidelines: a verification of linguistic validity	6
Assessment of the cardiorespiratory fitness and the quality of life of patients with breast cancer undergoing chemotherapy: a prospective study	6
An integrated analysis of microRNAs regulating DNA damage response in triple-negative breast cancer	6
CD1a- and CD83-positive dendritic cells as prognostic markers of metastasis development in early breast cancer patients	6
BAP1-defficient breast cancer in a patient with BAP1 cancer syndrome	6
Delayed breast reconstruction with autologous free flap after radiation therapy: vascular complications and aesthetic outcomes	6
The complex role of regulatory cells in breast cancer: implication for immunopathogenesis and immunotherapy	6
Machine learning applied in patient-reported outcome research—exploring symptoms in adjuvant treatment of breast cancer	6
A prospective cohort study of abemaciclib-induced interstitial lung disease in metastatic breast cancer after chemotherapy	6
Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT	6
Impact of serum vitamin D on the response and prognosis in breast cancer patients treated with neoadjuvant chemotherapy	5
Comparative study of the usefulness of adjunctive tomosynthesis in breast cancer screening by mammography and ultrasound in Japan	5
Impact of community-based exercise on fatigue in early breast cancer survivors: identifying potential determinants of change	5
Evaluation of quality of life in breast cancer patients who underwent breast-conserving surgery or mastectomy using real-world data	5
Specific types of anxiety regarding radiation therapy in patients with breast cancer: a longitudinal study	5
Options of locoregional therapy for primary foci of breast cancer influence the rate of nonregional lymph node metastasis in N2–N3 status patients: a SEER database analysis	5
FOXA1 of regulatory variant associated with risk of breast cancer through allele-specific enhancer in the Chinese population	5
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER databas	5
Japanese subgroup analysis of the phase 3 MONARCH 3 study of abemaciclib as initial therapy for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced brea	5
Patient preferences for features of HER2-targeted treatment of advanced or metastatic breast cancer: a discrete-choice experiment study	5
Prospective study of once-daily accelerated partial breast irradiation using 3-dimensional conformal external beam radiotherapy for Japanese women: 12-year outcomes, toxicity, and cosmesis	5
Racial differences in predictive value of the 21-gene recurrence score assay: a population-based study using the SEER database	5
Physicians’ perception about the impact of breast reconstruction on patient prognosis: a survey in Japan	5
SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer	5
Patterns of treatment and their outcomes in primary breast lymphoma; a comprehensive population-based analysis	5
Liquid biopsy using non-coding RNAs and extracellular vesicles for breast cancer management	5
Repeated sentinel lymph node biopsy for local recurrence after breast-conserving surgery	5
Racial and socioeconomic inequities in breast cancer screening before and during the COVID-19 pandemic: analysis of two cohorts of women 50 years +	5
Development and validation of a neoadjuvant chemotherapy pathological complete remission model based on Reg IV expression in breast cancer tissues: a clinical retrospective study	5
Prognosis difference between HER2-low and HER2-zero breast cancer patients: a systematic review and meta-analysis	5
Predictive value of immune genomic signatures from breast cancer cohorts containing data for both response to neoadjuvant chemotherapy and prognosis after surgery	5
CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients	5
Endoscopic mastectomy followed by immediate breast reconstruction with fat grafting for breast cancer	5
Non-irradiated area of intraoperative radiotherapy with electron technique: outcomes and pattern of failure in early-stage breast cancer from a single-center, registry study	5
Population-level impact of adjuvant trastuzumab emtansine on the incidence of metastatic breast cancer: an epidemiological prediction model of women with HER2-positive early breast cancer and residual	5
High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands	5
Quality of life and satisfaction of patients after oncoplastic or traditional breast-conserving surgery using the BREAST-Q (BCT module): a prospective study	4
A 5-year review of genomic medicine in breast cancer: insights from C-CAT data on 3776 Japanese patients	4
Significance of prostate/pancreatic/skin cancer family history for detecting BRCA2 pathogenic variant careers among patients with breast cancer	4
Breast cancer patient-reported outcome of factors influencing cosmetic satisfaction after breast-conserving therapy	4
A prospective comparison study utilizing patient-reported outcomes of taxane-related peripheral neuropathy between nab-paclitaxel and standard paclitaxel in patients with breast cancer	4
Overall survival in Japanese patients with ER+/HER2− advanced breast cancer treated with first-line palbociclib plus letrozole	4
Negative impact of the COVID-19 state of emergency on breast cancer screening participation in Japan	4
Is venous thromboembolism a time-dependent event in breast cancer patients taking tamoxifen?	4
Correlation between postoperative treatment selection and prognosis determined using the Oncotype DX® test data: a retrospective multicenter study in Japan	4
Clinical benefits of tomosynthesis-guided vacuum assisted breast biopsy: a comparison with stereotactic vacuum assisted biopsy	4
Effects of CBT-based interventions on health outcomes in breast cancer patients: a systematic review and Meta-analysis	4
Contrast-enhanced mammography in the management of breast architectural distortions and avoidance of unnecessary biopsies	4
Simultaneous integrated boost intensity-modulated radiotherapy post breast-conserving surgery: clinical efficacy, adverse effects, and cosmetic outcomes in breast cancer patients	4
Increasing survivors of anthracycline-related cardiomyopathy with breast cancer in trastuzumab era: thirty-one-year trends in a Japanese Community	4
LncRNA SNHG5 promotes the glycolysis and proliferation of breast cancer cell through regulating BACH1 via targeting miR-299	4
A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancer	4
The safety of performing breast reconstruction during the COVID-19 pandemic	4
Breast cancer drugs: FDA approval, development time, efficacy, clinical benefits, innovation, trials, endpoints, quality of life, value, and price	4
Association of molecular subtypes and treatment with survival in invasive micropapillary breast cancer: an analysis of the Surveillance, Epidemiology, and End Results database	4
Cost-effectiveness of clinical breast examination screening programme among HER2-positive breast cancer patients: a modelling study	4
Does breast-conserving surgery with radiotherapy in BRCA-mutation carriers significantly increase ipsilateral breast tumor recurrence? A systematic review and meta-analysis	4
Predictive and prognostic significance of BRCAness in HER2-negative breast cancer	4
Editorial: HBOC and high-risk screening: up-to-date	4
Interstitial lung disorders following postoperative radiotherapy with concurrent or sequential hormonal therapy for breast cancer: a nationwide database study in Japan	4
Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor reg	4
Postoperative cholesterol changes as early predictors of breast cancer-related lymphedema: a retrospective cohort study	4

Prognosis of isolated locoregional recurrence after early breast cancer with immediate breast reconstruction surgery: a retrospective multi‑institutional study	4
Cell-free biomimetic polyurethane-based scaffold for breast reconstruction following non-malignant lesion resection. A first-in-human study	4
The association of infectious mononucleosis and invasive breast cancer in The Health of Women (HOW) Study®	4
Defer surgery in operable breast cancer: how long is too long?	4
BAHD1 serves as a critical regulator of breast cancer cell proliferation and invasion	4
Correction: Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a mu	4
Effect of patient decision aids on decisional conflict and regret associated with breast cancer surgery: a randomized controlled trial	4
A novel system to provide information via online YouTube videos and an evaluation of current online information about hereditary breast cancer	4
A novel approach correlating pathologic complete response with digital pathology and radiomics in triple-negative breast cancer	4
Correction to: Effect of Wnt5a on drug resistance in estrogen receptor‑positive breast cancer	4
IRSN-23 gene diagnosis enhances breast cancer subtype classification and predicts response to neoadjuvant chemotherapy: new validation analyses	4
Constructing shared genetic architecture between bioavailable testosterone and luminal A breast cancer in female	4
Correction to: Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-li	4
Breast cancer screening rates and influencing factors among LGBTQ groups in Japan	4
Development and validation of a symptom illustration scale from the patient-reported outcome common terminology criteria for adverse events for patients with breast cancer	4
Acknowledgments to reviewers 2023	4
Effectiveness of eribulin as first-line or second-line chemotherapy for HER2-negative hormone-resistant advanced or metastatic breast cancer: findings from the multi-institutional, prospective, observ	3
Real-world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first- or second-line treatment for hormone receptor–	3
Expression and clinical significance of hypoxia-induced long non-coding RNA TCONS_I2_00001955 in breast cancer	3
Risk factors for early recurrence in patients with hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study in Japan (WJOG15721B)	3
Acknowledgments to reviewers 2022	3
Comparison of water- vs. land-based exercise for improving functional capacity and quality of life in patients living with and beyond breast cancer (the AQUA-FiT study): a randomized controlled trial	3
Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtype	3
Pilot trial of an electronic patient-reported outcome monitoring system in patients with metastatic breast cancer undergoing chemotherapy	3
A prospective analysis of two studies that used the 5-mm interval slices and 5-mm margin-free method for ipsilateral breast tumor recurrence after breast-conserving surgery without radiotherapy	3
Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1	3
Effectiveness and tasks of breast MRI surveillance for high-risk women with cancer susceptibility genes other than BRCA1/2: a single institution study	3
Microsurgical techniques in the treatment of breast cancer-related lymphedema: a systematic review of efficacy and patient outcomes	3
Fatigue and quality of life during neoadjuvant chemotherapy of early breast cancer: a prospective multicenter cohort study	3
Impact of immediate breast reconstruction on perioperative therapy: insights from a Japanese Nationwide Registry	3
Deep learning model with collage images for the segmentation of dedicated breast positron emission tomography images	3
Characterization of protein-based risk signature to predict prognosis and evaluate the tumor immune environment in breast cancer	3
Correction to: Challenges and future directions in breast cancer care in Fukushima prefecture in Japan: correspondence to “A survey on the current status of clinical resources for diagnosis and treatm	3
Surgical treatment trends and identification of primary breast tumors after surgery in occult breast cancer: a study based on the Japanese National Clinical Database—Breast Cancer Registry	3
The association between physical health-related quality of life, physical functioning, and risk of contralateral breast cancer among older women	3
Reply to the Letter to the editor “Does axillary lymph node recurrence breast cancer subtype information matter for prognosis estimation?”	3
A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using multicatheter interstitial brachytherapy: clinical results with a median follow-up of 60 mo	3
Dietary intake of branched-chain amino acids in relation to the risk of breast cancer	3
Follow-up of tissue genomics in BRCA1/2 carriers who underwent prophylactic surgeries	3
Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry	3
miR-4796 enhances the sensitivity of breast cancer cells to ionising radiation by impairing the DNA repair pathway	3
Efficacy and feasibility of neoadjuvant pembrolizumab plus chemotherapy for early-stage triple-negative and estrogen receptor low, HER2-negative breast cancer: a Japanese single-institution real-world	3
Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort study	3
Neurospora crassa is a potential source of anti-cancer agents against breast cancer	3
Real-world incidence of and risk factors for abemaciclib-induced interstitial lung disease in Japan: a nested case–control study of abemaciclib-induced interstitial lung disease (NOSIDE)	3
Wrapping up the evidence: bandaging in breast cancer-related lymphedema—a systematic review and meta-analysis	3
Clinical utility of tumor-infiltrating lymphocyte evaluation by two different methods in breast cancer patients treated with neoadjuvant chemotherapy	3
KLF11 is an independent negative prognostic factor for breast cancer from a cohort study and induces proliferation and inhibits apoptosis in vitro	3
French national survey on breast cancer care: caregiver and patient views	3
Digitally quantified area of residual tumor after neoadjuvant chemotherapy in HER2-positive breast cancer	3
Association of lymphatic flow velocity with surgical outcomes in patients undergoing lymphovenous anastomosis for breast cancer-related lymphedema	3
Antitumor effects of co-treatment of resveratrol with antitumor drugs in ER- and HER2-positive breast cancer cells are due to induction of apoptosis and modulation of estrogen receptor expression	2
Prognostici of ER-staining patterns and heterogeneity of ER positive HER2 negative breast cancer	2
Survival trends and patient characteristics between 2004 and 2016 for breast cancer in Japan based on the National Clinical Database-Breast Cancer Registry	2
A risk scoring system based on tumor microenvironment cells to predict prognosis and immune activity in triple-negative breast cancer	2
Radiation-induced angiosarcoma of the breast: retrospective analysis at a regional treatment centre	2
Severity and risk factors of interval breast cancer in Queensland, Australia: a population-based study	2
Correction to: miR-145, miR-205 and miR-451: potential tumor suppressors involved in the progression of in situ to invasive carcinoma of the breast	2
Effects of exercise on cancer-related cognitive impairment in breast cancer survivors: a scoping review	2
High-accuracy prediction of axillary lymph node metastasis in invasive lobular carcinoma using focal cortical thickening on magnetic resonance imaging	2
A nomogram to predict the benefit of postmastectomy radiotherapy in breast cancer with nodal micrometastases	2
Centrally located breast carcinomas treated with central quadrantectomy and immediate nipple–areola reconstruction: a cohort study	2
Tetraspanins CD63 and CD81 as potential prognostic biomarkers in breast cancer	2
Correction to: Racial and socioeconomic inequities in breast cancer screening before and during the COVID-19 pandemic: analysis of two cohorts of women 50 years +	2
Development and validation of a predictive risk tool for VTE in women with breast cancer under chemotherapy: a cohort study in China	2
Alteration of Trop-2 expression in breast cancer cells by clinically used therapeutic agents and acquired tamoxifen resistance	2
Quality of life in women with breast cancer undergoing neoadjuvant chemotherapy: comparison between PICC and PICC-port	2
Adipose-derived stem cells enhance the tumorigenic potential of pre-malignant breast epithelial cells through paracrine activation of PI3K–AKT pathway	2
Returning individual genomic results to population-based cohort study participants with BRCA1/2 pathogenic variants	2
Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer	2
Risk factors for arm lymphedema following breast cancer surgery: a Japanese nationwide database study of 84,022 patients	2
Reply to comment on ‘An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2	2
Adjuvant chemotherapy in T1a/bN0 breast cancer with a high 21-gene recurrence score (> 25): a 10-year follow-up in a real-world cohort	2
Real-world progression-free survival and overall survival of palbociclib plus endocrine therapy (ET) in Japanese patients with hormone receptor-positive/human epidermal growth factor receptor 2-negati	2
2020 Annual Report of National Clinical Database-Breast Cancer Registry: 10-year mortality of elderly breast cancer patients in Japan	2
Clinical outcomes after post-operative radiotherapy for breast cancer patients presenting with ipsilateral supraclavicular metastasis: considerations on the cranial border of irradiation field	2
Not all patients with premenopausal breast cancer will experience the negative effects of tamoxifen treatment on their bone mineral density	2
What affects women’s decision-making on breast reconstruction after mastectomy for breast cancer?	2
A cost-consequences analysis of the SAFE trial: a comparative, effectiveness trial evaluating high- versus low-supervision of an exercise intervention for women with breast cancer	2
Significance of skeletal muscle index-to-body mass index ratio as a predictor of post-surgical bleeding after mastectomy in patients with breast cancer	2
The role of the BTLA–HVEM complex in the pathogenesis of breast cancer	2
Advances in the study of autophagy in breast cancer	2
Optimal patient population for adjuvant S-1 therapy in hormone receptor-positive, HER2-negative early breast cancer	2
Predictors of delayed breast reconstruction in the Netherlands: a 5-year follow-up study in stage I–III breast cancer patients	2
Artificial intelligence computer-aided detection enhances synthesized mammograms: comparison with original digital mammograms alone and in combination with tomosynthesis images in an experimental sett	2
Conservative axillary surgery is emerging in the surgical management of breast cancer	2
Characteristics, treatment trends, and long-term outcomes of Japanese patients with pregnancy-associated breast cancer (PABC)	2
Predictors of persistent post-surgical pain intensity and interference at 1 year after breast cancer surgery: assessing central sensitization, central sensitivity symptoms, and psychological factors	2
PI3K/AKT and MAPK1 molecular changes preceding matrix metallopeptidases overexpression during tamoxifen-resistance development are correlated to poor prognosis in breast cancer patients	2
Clinical outcomes and patient satisfaction with the use of biological and synthetic meshes in one-stage implant-based breast reconstruction	2
Detection of high-risk patients resistant to CDK4/6 inhibitors with hormone receptor-positive HER2-negative advanced and metastatic breast cancer in Japan (KBCSG-TR-1316)	2
Feasibility of accelerated partial breast irradiation with strut-adjusted volume implant brachytherapy in Japan focusing on dosimetry and acute toxicity: a Japanese multi-institutional prospective stu	2
Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer	2
Identifying subgroups of ypN1 breast cancer patients who may exempt from axillary lymph node dissection after neoadjuvant chemotherapy: insights from a large cohort study	2
Phase 1 study of oral selective estrogen receptor degrader (SERD) amcenestrant (SAR439859), in Japanese women with ER-positive and HER2-negative advanced breast cancer (AMEERA-2)	2